Basic Information
| LncRNA/CircRNA Name | CASC11 |
| Synonyms | NA |
| Region | GRCh38_8:127686343-127733967 |
| Ensemble | ENSG00000249375 |
| Refseq | NR_117101 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR |
| Sample | cell lines(HT-1197,HT-1376) |
| Expression Pattern | up-regulated |
| Function Description | In this study we showed that plasma lncRNA CASC11 was upregulated, while plasma miRNA-150 was downregulated in patients with early-stage bladder cancer than in healthy controls. |
| Pubmed ID | 30916832 |
| Year | 2019 |
| Title | lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. |
External Links
| Links for CASC11 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |